References
- Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol. 1999;246:339–346.
- Porges Y, Blumen S, Fireman Z, et al. Cyclosporine-induced optic neuropathy, ophthalmoplegia, and nystagmus in a patient with Crohn disease. Am J Ophthalmol. 1998;126:607–609.
- Prud'homme GJ, Parfrey NA, Vanier LE. Cyclosporine-induced autoimmunity and immune hyperreactivity. Autoimmunity. 1991;9:345–356.
- Jansen O, Krieger D, Krieger S, et al. Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy. AJNR Am J Neuroradiol. 1996;17:337–344.
- Wijdicks EF, Wiesner RH, Krom RA. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology. 1995;45:1962–1964.
- Munhoz RP, Teive HA, Germiniani FM, et al. Movement disorders secondary to long-term treatment with cyclosporine A. Arq Neuropsiquiatr. 2005;63:592–596.
- Ling H, Bhidayasiri R. Reversible parkinsonism after chronic cyclosporin treatment in renal transplantation. Mov Disord. 2009;24:1848–1849.
- Miklavcic P, Avcin S, Jazbec J, et al. Cyclosporine A induced dystonia-parkinsonism. J Neurol Sci. 2017;375:68–70.
- Derici U, Arinsoy T, Sindel S, et al. Cyclosporine-A induced neurotoxicity after renal transplantation. Acta Neurol Belg. 2001;101:124–127.
- Kim HC, Han SY, Park SB, et al. Parkinsonism during cyclosporine treatment in renal transplantation. Nephrol Dial Transplant. 2002;17:319–321.